Brief: Bioceltix Completes TAS Study For BCX-EM Medical Product

Bioceltix SA

09/03/2023 07:41

March 9 (Reuters) - Bioceltix SA  BCXP.WA :
    * SAID ON WEDNESDAY IT HAS RECEIVED FINAL REPORT ON TARGET
ANIMAL
SAFETY (TAS) STUDY FOR ITS BCX-EM MEDICAL PRODUCT
    * SAID PRODUCT USED IN TREATMENT OF OSTEOARTHRITIS IN HORSES
    * THE STUDY SHOWN THAT DOUBLE JOINT INJECTION OF BCX-EM IS
SAFE
AND DOES NOT CAUSE ANY SERIOUS OR UNEXPECTED SIDE EFFECTS

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nEM28G1jka
 Further company coverage:  BCXP.WA  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))